Sugi Predict

Sugi Predict / Compounds / SCHEMBL23273225

SCHEMBL23273225

SCHEMBL23273225

CSCCC(N)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(N)=O)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ TFPI P10646 1/20 0.54
▸ OPRL1 P41146 2/20 0.51
▸ PTH1R Q03431 2/20 0.51
▸ CCKBR P32239 3/20 0.49
▸ BACE1 P56817 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20764456 0.94 TFPI (0.57) TFPIOPRL1BACE1
SCHEMBL31678873 0.92 TFPI (0.56) TFPIOPRL1PTH1RBACE1
SCHEMBL30421823 0.91 TFPI (0.61) TFPIBACE1
SCHEMBL20764468 0.90 TFPI (0.56) TFPIOPRL1CCKBRBACE1
SCHEMBL23273227 0.90 CCKBR (0.61) PTH1RCCKBR
SCHEMBL30930548 0.89 PTH1R (0.54) TFPIPTH1R
SCHEMBL29622911 0.89 TFPI (0.62) TFPIOPRL1BACE1
SCHEMBL30524359 0.87 TFPI (0.61) TFPICCKBR
SCHEMBL30435346 0.87 TFPI (0.66) TFPIOPRL1PTH1R
SCHEMBL30642059 0.87 TFPI (0.66) TFPIOPRL1PTH1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911451-B2 Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers ImmuLogix Ltd (US) 2024-02-27 — — US disclosed
US-20210121546-A1 COMPOSITION OF TUMOR-ASSOCIATED PROLIFERATIVE PEPTIDES AND RELATED ANTI-CANCER IMMUNOGEN FOR THE TREATMENT OF LUNG CANCERS AND OTHER CANCERS ImmuLogix Ltd (US) 2021-04-29 — — US disclosed
Send feedback